Danske Bank’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Danske Bank's RVMD Position: Q3 2026 in Review
Danske Bank increased its Revolution Medicines (RVMD) stake by 7.6% in Q3 2026, buying an estimated $1.19M and bringing the position to 85,200 shares worth $17.5M. The position accounts for 0.03% of the portfolio, ranked #346.
Danske Bank first reported a position in RVMD in Q3 2024 and has held it in 9 quarters since. 754 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Danske Bank held 85,200 shares of Revolution Medicines worth $17.5M as of Q3 2026.
- Danske Bank bought 6,000 Revolution Medicines shares in Q3 2026, an estimated $1.19M.
- Revolution Medicines made up 0.03% of Danske Bank's portfolio in Q3 2026, its #346 holding.
- Danske Bank first reported a position in Revolution Medicines in Q3 2024 and has held it in 9 quarters since.
- 754 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.